Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells

<b>Background</b>: The differentiation process of human mesenchymal stem cells (hMSCs) is regulated by a variety of chemical, physical, and biological factors. These factors activate distinct signaling pathways and transcriptional networks, thereby regulating the lineage-specific differe...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuqing Han, Hongyang Ma, Zhihui Tang, Chanyuan Jin
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/13/4/947
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850156147362758656
author Yuqing Han
Hongyang Ma
Zhihui Tang
Chanyuan Jin
author_facet Yuqing Han
Hongyang Ma
Zhihui Tang
Chanyuan Jin
author_sort Yuqing Han
collection DOAJ
description <b>Background</b>: The differentiation process of human mesenchymal stem cells (hMSCs) is regulated by a variety of chemical, physical, and biological factors. These factors activate distinct signaling pathways and transcriptional networks, thereby regulating the lineage-specific differentiation of hMSCs. <b>Objective</b>: This study aims to investigate the role of Immediate Early Response 3 (IER3) in the osteogenic differentiation of human mesenchymal stem cells (hMSCs) and explore the underlying regulatory mechanisms by which IER3 influences osteogenesis. <b>Methods</b>: The expression levels of IER3 and osteogenesis-related genes were quantified when hMSCs were subjected to in vitro osteogenic induction. Then, stable IER3–knockdown hMSCs were generated using IER3–targeted shRNA lentiviral vectors, and the impact of IER3 on osteogenic differentiation was evaluated through both in vitro cell induction and hMSCs subcutaneous implantation model of nude mice. Moreover, RNA–seq and functional inhibition assays were performed to elucidate the signaling pathway through which IER3 regulates the osteogenic differentiation of hMSCs. <b>Results</b>: IER3 expression was significantly downregulated during osteogenic differentiation. Knockdown of IER3 markedly upregulated the expression of ALP and RUNX2, enhancing the osteogenic differentiation capacity of hMSCs, both in vitro and in vivo. Mechanistic studies revealed that IER3 knockdown significantly increased phosphorylated ERK1/2 levels, activating the MAPK/ERK signaling pathway. Furthermore, inhibition of the MAPK/ERK signaling pathway reversed the enhanced osteogenic differentiation observed following IER3 knockdown. <b>Conclusions</b>: Knockdown of IER3 promotes osteogenic differentiation of hMSCs through regulation of the MAPK/ERK signaling pathway, indicating IER3 represents a potential therapeutic target for the treatment of osteoporosis and bone defect-related diseases.
format Article
id doaj-art-72c2efe9245347f5bd9599982df879a9
institution OA Journals
issn 2227-9059
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-72c2efe9245347f5bd9599982df879a92025-08-20T02:24:39ZengMDPI AGBiomedicines2227-90592025-04-0113494710.3390/biomedicines13040947Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem CellsYuqing Han0Hongyang Ma1Zhihui Tang2Chanyuan Jin3Second Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases, Beijing 100081, ChinaSecond Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases, Beijing 100081, ChinaSecond Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases, Beijing 100081, ChinaSecond Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases, Beijing 100081, China<b>Background</b>: The differentiation process of human mesenchymal stem cells (hMSCs) is regulated by a variety of chemical, physical, and biological factors. These factors activate distinct signaling pathways and transcriptional networks, thereby regulating the lineage-specific differentiation of hMSCs. <b>Objective</b>: This study aims to investigate the role of Immediate Early Response 3 (IER3) in the osteogenic differentiation of human mesenchymal stem cells (hMSCs) and explore the underlying regulatory mechanisms by which IER3 influences osteogenesis. <b>Methods</b>: The expression levels of IER3 and osteogenesis-related genes were quantified when hMSCs were subjected to in vitro osteogenic induction. Then, stable IER3–knockdown hMSCs were generated using IER3–targeted shRNA lentiviral vectors, and the impact of IER3 on osteogenic differentiation was evaluated through both in vitro cell induction and hMSCs subcutaneous implantation model of nude mice. Moreover, RNA–seq and functional inhibition assays were performed to elucidate the signaling pathway through which IER3 regulates the osteogenic differentiation of hMSCs. <b>Results</b>: IER3 expression was significantly downregulated during osteogenic differentiation. Knockdown of IER3 markedly upregulated the expression of ALP and RUNX2, enhancing the osteogenic differentiation capacity of hMSCs, both in vitro and in vivo. Mechanistic studies revealed that IER3 knockdown significantly increased phosphorylated ERK1/2 levels, activating the MAPK/ERK signaling pathway. Furthermore, inhibition of the MAPK/ERK signaling pathway reversed the enhanced osteogenic differentiation observed following IER3 knockdown. <b>Conclusions</b>: Knockdown of IER3 promotes osteogenic differentiation of hMSCs through regulation of the MAPK/ERK signaling pathway, indicating IER3 represents a potential therapeutic target for the treatment of osteoporosis and bone defect-related diseases.https://www.mdpi.com/2227-9059/13/4/947human mesenchymal stem cellsIER3osteogenicMAPK/ERK signalingdifferentiation
spellingShingle Yuqing Han
Hongyang Ma
Zhihui Tang
Chanyuan Jin
Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells
Biomedicines
human mesenchymal stem cells
IER3
osteogenic
MAPK/ERK signaling
differentiation
title Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells
title_full Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells
title_fullStr Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells
title_full_unstemmed Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells
title_short Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells
title_sort knockdown of ier3 promotes osteogenic differentiation of human mesenchymal stem cells
topic human mesenchymal stem cells
IER3
osteogenic
MAPK/ERK signaling
differentiation
url https://www.mdpi.com/2227-9059/13/4/947
work_keys_str_mv AT yuqinghan knockdownofier3promotesosteogenicdifferentiationofhumanmesenchymalstemcells
AT hongyangma knockdownofier3promotesosteogenicdifferentiationofhumanmesenchymalstemcells
AT zhihuitang knockdownofier3promotesosteogenicdifferentiationofhumanmesenchymalstemcells
AT chanyuanjin knockdownofier3promotesosteogenicdifferentiationofhumanmesenchymalstemcells